Sirt1 agonists such as resveratrol can alleviate glomerular injury in proteinuric kidney disease [21], while podocyte-specific deletion of Sirt1 aggravates proteinuria and podocyte injury in mice with ADR or DN [22, 23]. The gene discussed is SIRT1; the disease is liver dysplastic nodule.